InvestorsHub Logo
Followers 30
Posts 5046
Boards Moderated 0
Alias Born 01/07/2020

Re: ziploc_1 post# 270966

Saturday, 05/02/2020 5:13:59 PM

Saturday, May 02, 2020 5:13:59 PM

Post# of 425654
ziploc@ I'm late on this train - bying in first time september 2018 shortly before R-I was released - so compared to a lot of people here on iHub AMRN (who has been here for big part of their life's) I'm very New.
----------------------

This is why - I'm only now beginning to understand the real basis for the Patent Trial.

What Hikma and Reddy did in their plans - was (as I now understand it) what generic producers does - when patens 'Run Out' - prepare to make a Generic alternative to the Brand name drug - in this case Vascepa.
----------------------

The Short Version - Now after R-I succes - Amarin says to generics - this is now 'A Much More Valuable Drug'.

We have, through our R-I 300 million$ trials 'Proved', - that our Purified Form of EPA has an unprecedented positive effect for CDV people.

The patent case rolls with ruling on marts 30. 2020.
----------------------

I do not doubt for a second that, given the arguments of John Thero, Amarin shall/will WIN Appeal case.

If they dont' you might just as well 'Close down US Patent Office' - and all future research and science, would be shot down for ever - in God's own country


Jasbg
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News